Brief: Alkem Laboratories Q3 Consol Net Profit 6.36 Billion Rupees
13/02/2026 08:21
Feb 13 (Reuters) - Alkem Laboratories Ltd ALKE.NS: Q3 CONSOL NET PROFIT 6.36 BILLION RUPEES; IBES PROFIT EST. 6.51 BILLION RUPEES Q3 CONSOL REVENUE FROM OPERATIONS 37.37 BILLION RUPEES; IBES EST. 37.6 BILLION RUPEES DIVIDEND OF 43 RUPEES PER SHARE Source text: ID:nBSE5f14MW Further company coverage: ALKE.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees